REFRACTORY CANCER

REFRACTORY CANCER was reported 214 times

REFRACTORY CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 14 0.0024
1 CD19-directed Chimeric Antigen Receptor [EPC] 17 0.0017
2 Glycolipid Disialoganglioside-directed Antibody [EPC] 1 0.0009
3 Topoisomerase Inhibitor [EPC] 50 0.0006
4 BCL-2 Inhibitor [EPC] 26 0.0004
5 Alkylating Drug [EPC] 72 0.0003
6 Histone Deacetylase Inhibitor [EPC] 1 0.0003
7 Proteasome Inhibitor [EPC] 29 0.0003
8 Platinum-based Drug [EPC] 63 0.0002
9 Microtubule Inhibitor [EPC] 38 0.0002
10 CD52-directed Cytolytic Antibody [EPC] 4 0.0002
11 SLAMF7-directed Immunostimulatory Antibody [EPC] 1 0.0002
12 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 4 0.0002
13 Nucleoside Metabolic Inhibitor [EPC] 47 0.0002
14 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
15 CD20-directed Cytolytic Antibody [EPC] 35 0.0001
16 CD30-directed Immunoconjugate [EPC] 1 0.0001
17 Leukocyte Growth Factor [EPC] 11 0.0001
18 Thalidomide Analog [EPC] 39 0.0001
19 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
20 Corticosteroid [EPC] 88 0.0001
21 Nitrofuran Antibacterial [EPC] 1 0.0001
22 Kinase Inhibitor [EPC] 29 0.0001
23 Folate Analog Metabolic Inhibitor [EPC] 21 0.0000
24 Protease Inhibitor [EPC] 2 0.0000
25 Azole Antifungal [EPC] 7 0.0000
26 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
27 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
28 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
29 Androgen Receptor Inhibitor [EPC] 3 0.0000
30 Serotonin-3 Receptor Antagonist [EPC] 5 0.0000
31 Phenothiazine [EPC] 1 0.0000
32 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
33 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 3 0.0000
34 Programmed Death Receptor-1 Blocking Antibody [EPC] 3 0.0000
35 Polyene Antifungal [EPC] 1 0.0000
36 Estrogen Receptor Antagonist [EPC] 1 0.0000
37 Vascular Endothelial Growth Factor Inhibitor [EPC] 4 0.0000
38 Prostaglandin Analog [EPC] 2 0.0000
39 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
40 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
41 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
42 Tetracycline-class Drug [EPC] 1 0.0000
43 HER2/neu Receptor Antagonist [EPC] 1 0.0000
44 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
45 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
46 Interferon beta [EPC] 2 0.0000
47 Purine Antimetabolite [EPC] 1 0.0000
48 RANK Ligand Inhibitor [EPC] 2 0.0000
49 Aromatase Inhibitor [EPC] 1 0.0000
50 Fluoroquinolone Antibacterial [EPC] 1 0.0000
51 Osmotic Laxative [EPC] 2 0.0000
52 Loop Diuretic [EPC] 3 0.0000
53 Expectorant [EPC] 1 0.0000
54 Thiazide Diuretic [EPC] 1 0.0000
55 Anti-epileptic Agent [EPC] 1 0.0000
56 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
57 Opioid Agonist [EPC] 1 0.0000
58 Vitamin D [EPC] 1 0.0000
59 Vitamin B12 [EPC] 1 0.0000
60 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
61 Benzodiazepine [EPC] 2 0.0000
62 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
63 Vitamin C [EPC] 1 0.0000
64 Insulin Analog [EPC] 1 0.0000
65 Platelet Aggregation Inhibitor [EPC] 1 0.0000
66 Proton Pump Inhibitor [EPC] 1 0.0000
67 Tumor Necrosis Factor Blocker [EPC] 1 0.0000